Close

Articles Posted in Product Liability

Updated:

Byetta, Januvia & Victoza Pancreatic Cancer Risk

Recent medical research suggests that certain type 2 diabetic medications, known as Incretin Mimetics, including Januvia, Janumet, Byetta, Bydureon and Victoza, are potentially linked to an increased risk of pancreatic cancer side effects when compared to other diabetes treatment. Incretin Mimetic Investigation Timeline April 18, 2013 – Institute for Safe…

Updated:

New Report: Pancreatic Cancer Risk from Byetta, Januvia, Victoza

According to the Institute for Safe Medication Practices (ISMP)’s Quarter Watch report, the number of pancreatic cancer cases are increasing involving lethal side effects of Byetta, Januvia, Victoza and other diabetes drugs known as incretin mimetics. ISMP evaluates adverse event reports submitted to the FDA, and the report, Perspectives on…

Updated:

Januvia, Janumet, Byetta, Victoza Heading to Federal MDL

The U.S. Judicial Panel on Multidistrict Litigation (JPML) has received a request to consolidate all federal pancreatic cancer lawsuits. These were filed by patients using Januvia, Janumet, Byetta and Victoza incretin mimetic diabetic drugs and they allege that they developed pancreatic cancer. The injured pancreatic cancer plaintiffs have requested that…

Updated:

FDA Investigates Pancreatic Cancer Link to Newer Diabetes Drugs

As a Texas medical doctor and Dallas Januvia/Byetta/Victoza dangerous drug Pancreatic Cancer attorney I am providing this latest information and investigation from the FDA. According to the FDA notice, posted on March 14, the agency is: “Evaluating unpublished new findings by a group of academic researchers that suggest an increased…

Updated:

Januvia, Byetta and Victoza Diabetes Drugs Risk For Pancreatic Cancers

According to a recent medical study, patients taking the newer diabetes drugs were affected by pancreatic cell growth and damage that may turn cancerous. The study, by UCLA Medical Center, provides evidence of increased pre-cancerous changes in diabetic patients using incretin mimetics drugs such as Januvia, Byetta and Victoza. FDA…

Contact Us
Start Chat